Verapamil is associated with all of the following except?
Now, the options are missing, but the correct answer is supposed to be one that's not associated. Let's think of typical options. Let's say the options are: A. Constipation B. Bronchodilation C. Hypotension D. Negative inotropic effect.
Verapamil does cause constipation as a common side effect because it slows gut motility. Hypotension is a known side effect due to vasodilation. It has a negative inotropic effect, which is why it's used in certain arrhythmias but contraindicated in heart failure. However, Verapamil is a non-dihydropyridine CCB, so it doesn't cause bronchodilation. In fact, it might worsen asthma because of its bronchoconstrictive potential. So the exception here would be Bronchodilation, which would be the correct answer.
**Core Concept**
Verapamil is a non-dihydropyridine calcium channel blocker (CCB) primarily used for hypertension, angina, and arrhythmias. Its pharmacological effects include **vasodilation, negative chronotropy, and negative inotropy**, with **gastrointestinal side effects** like constipation. It acts by inhibiting **L-type calcium channels** in vascular smooth muscle and cardiac tissue.
**Why the Correct Answer is Right**
Verapamil reduces intracellular calcium influx, decreasing myocardial contractility (negative inotropy) and conduction velocity (negative dromotropy). It causes **peripheral vasodilation**, **bradycardia**, and **constipation**. However, **bronchodilation** is not a feature—non-dihydropyridine CCBs like Verapamil may paradoxically worsen bronchospasm due to reduced smooth muscle relaxation in airways, unlike dihydropyridines (e.g., Nifedipine).
**Why Each Wrong Option is Incorrect**
**Option A:** *Constipation* is correct—Verapamil slows gut motility by inhibiting smooth muscle contraction.
**Option C:** *Hypotension* is correct—vasodilation from calcium channel blockade lowers systemic vascular resistance.
**Option D:** *Negative inotropic effect* is correct—reduces cardiac contractility, which is why it’s contraindicated in severe heart failure.
**Clinical Pearl / High-Yield Fact**
Differentiate **non-dihydropyridine CCBs** (Verapamil, Diltiazem) from **dihydropyridines** (Nifedipine): the former cause **negative inotropy and bradycardia**, while the latter are **pure vasodilators**. Never use non-dihydropyridines in patients with **severe heart failure or asthma**.
**Correct Answer: B. Bronchodilation**